Showing 1 to 8 of 8 results


Rising Kidney Cancer Cases Prompt Early Detection Urge
A kidney cancer specialist urges Britons to be vigilant for six early symptoms often mistaken for common health issues, stressing the importance of early detection for improved survival rates, as cases rise sharply among younger adults.
Rising Kidney Cancer Cases Prompt Early Detection Urge
A kidney cancer specialist urges Britons to be vigilant for six early symptoms often mistaken for common health issues, stressing the importance of early detection for improved survival rates, as cases rise sharply among younger adults.
Progress
20% Bias Score


Promising Phase 1 Results for Personalized Kidney Cancer Vaccine NeoVax
A phase 1 trial of NeoVax, a personalized cancer vaccine for kidney cancer, showed promising results in 9 patients, with all remaining disease-free after nearly three years; the vaccine induced a significant increase in T cells, highlighting its potential to prevent recurrence.
Promising Phase 1 Results for Personalized Kidney Cancer Vaccine NeoVax
A phase 1 trial of NeoVax, a personalized cancer vaccine for kidney cancer, showed promising results in 9 patients, with all remaining disease-free after nearly three years; the vaccine induced a significant increase in T cells, highlighting its potential to prevent recurrence.
Progress
40% Bias Score


Personalized Cancer Vaccine Shows Promise in Advanced Kidney Cancer
A small study of nine patients with advanced kidney cancer showed promising results using a personalized vaccine targeting neoantigens; after three years, all patients remained cancer-free, suggesting a new approach to treating this challenging disease.
Personalized Cancer Vaccine Shows Promise in Advanced Kidney Cancer
A small study of nine patients with advanced kidney cancer showed promising results using a personalized vaccine targeting neoantigens; after three years, all patients remained cancer-free, suggesting a new approach to treating this challenging disease.
Progress
44% Bias Score


Australian Father Races Against Time to Fund Emergency Kidney Cancer Surgery
A 57-year-old Australian father, Shakir Pichler, needs $\text{~}15,000 for an emergency kidney tumor removal surgery scheduled for December 18 due to a three-month wait in the public system; a GoFundMe campaign is underway.
Australian Father Races Against Time to Fund Emergency Kidney Cancer Surgery
A 57-year-old Australian father, Shakir Pichler, needs $\text{~}15,000 for an emergency kidney tumor removal surgery scheduled for December 18 due to a three-month wait in the public system; a GoFundMe campaign is underway.
Progress
48% Bias Score

Ozempic Weight Loss Drugs Linked to Increased Kidney Cancer Risk
A major study of 86,000 patients revealed that while weight-loss drugs like Ozempic lower the risk of 16 cancers by 17 percent, they may increase kidney cancer risk by 33 percent, prompting calls for further research.

Ozempic Weight Loss Drugs Linked to Increased Kidney Cancer Risk
A major study of 86,000 patients revealed that while weight-loss drugs like Ozempic lower the risk of 16 cancers by 17 percent, they may increase kidney cancer risk by 33 percent, prompting calls for further research.
Progress
60% Bias Score

Personalized Cancer Vaccine Shows Promise in Treating Advanced Kidney Cancer
A new personalized cancer vaccine shows promise in treating advanced kidney cancer; in a small study, nine patients with stage 3 or 4 kidney cancer remained cancer-free for an average of 34.7 months after receiving a vaccine tailored to their specific tumor type, triggering a significant immune resp...

Personalized Cancer Vaccine Shows Promise in Treating Advanced Kidney Cancer
A new personalized cancer vaccine shows promise in treating advanced kidney cancer; in a small study, nine patients with stage 3 or 4 kidney cancer remained cancer-free for an average of 34.7 months after receiving a vaccine tailored to their specific tumor type, triggering a significant immune resp...
Progress
40% Bias Score

Personalized Cancer Vaccine Shows Promising Results in Kidney Cancer Trial
A phase I trial at Dana-Farber Cancer Institute showed that a personalized cancer vaccine kept nine kidney cancer patients cancer-free for three years post-treatment; this is a significant advancement given the high recurrence rate of kidney cancer.

Personalized Cancer Vaccine Shows Promising Results in Kidney Cancer Trial
A phase I trial at Dana-Farber Cancer Institute showed that a personalized cancer vaccine kept nine kidney cancer patients cancer-free for three years post-treatment; this is a significant advancement given the high recurrence rate of kidney cancer.
Progress
40% Bias Score

Arsenic in US Drinking Water Linked to Increased Kidney Cancer Risk
A Texas A&M University study reveals a link between arsenic in drinking water and increased kidney cancer risk, affecting up to 40 million Americans, particularly those using private wells; even low FDA-approved arsenic levels show a 6% increased risk.

Arsenic in US Drinking Water Linked to Increased Kidney Cancer Risk
A Texas A&M University study reveals a link between arsenic in drinking water and increased kidney cancer risk, affecting up to 40 million Americans, particularly those using private wells; even low FDA-approved arsenic levels show a 6% increased risk.
Progress
40% Bias Score
Showing 1 to 8 of 8 results